Rates of Endometrial Cancer Vary for U.S., Caribbean Black Women
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, June 26, 2023 -- Caribbean Black women have lower rates of endometrioid and nonendometrioid endometrial cancer (EC) than U.S. non-Hispanic Black women, according to a study published online June 26 in Cancer.
Heidy N. Medina, Ph.D., M.P.H., from the University of Miami School of Medicine, and colleagues examined EC vulnerability among a wider spectrum of African descent populations. Based on cancer registry data, 34,789 EC cases were analyzed from Florida (2005 to 2018), Martinique (2005 to 2018), and Guadeloupe (2008 to 2018).
The researchers found that the lowest rates for endometrioid and nonendometrioid subtypes were seen for Caribbean Black women. Nonendometrioid types were most common among U.S. non-Hispanic Blacks (9.2 per 100,000), with incidence much higher than among non-Hispanic Whites (incidence rate ratio, 2.60). For endometrioid EC, the rates increased 1.8 and 1.2 percent yearly from 2005 to 2018 for U.S. non-Hispanic Blacks and U.S. non-Hispanic Whites, respectively, while no change was seen for Caribbean Blacks. For nonendometrioid carcinomas, the rates increased 5.6, 4.4, and 3.9 percent for U.S. non-Hispanic Blacks, Caribbean Blacks, and non-Hispanic Whites, respectively.
"This study informs the current scientific evidence about endometrial cancer risk among a diverse sample of African descent women, highlighting that within-group differences matter among Black women," Medina said in a statement. "Our study suggests that these differences among Black women in different regions of the world are partly due to social factors associated with assigned race rather than purely African ancestry-related factors based on genetic origin."
Two authors disclosed ties to industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Recommendations Issued for Palliative RT for Symptomatic Bone Mets
THURSDAY, May 30, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online May 22 in Practical Radiation Oncology...
Living Outside of Comprehensive Cancer Center Catchment Area Tied to Later-Stage Diagnosis
TUESDAY, May 28, 2024 -- Disadvantaged populations and those living outside of a comprehensive cancer center's main catchment area have higher odds of receiving a diagnosis of...
Disparities Seen in Cancer Treatment Delivery at Minority-Serving Hospitals
TUESDAY, May 28, 2024 -- There are systemic disparities in definitive cancer treatment delivery at minority-serving hospitals (MSHs) versus non-MSHs, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.